These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2877752)

  • 21. Medical interventions in acute myocardial infarction.
    Sleight P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S113-9. PubMed ID: 11527113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nitrate therapy during and after acute myocardial infarction].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3377-80. PubMed ID: 14713972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infarct size reduction: a review of clinical trials.
    Fitzsimons TJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S34-7. PubMed ID: 2483230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision making in the routine management of myocardial infarction.
    Deshmukh H; Weil MH; Rackow EC
    Acute Care; 1986; 12(2):95-107. PubMed ID: 2899371
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of myocardial infarct in ambulatory practice].
    Duck HJ; Trenckmann H; Fleischmann JH; Neugebauer A; Schauer J
    Z Gesamte Inn Med; 1975 Apr; 30(8):311-5. PubMed ID: 51543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective drugs in preventing recurrent coronary events. I. Hospital phase.
    Rapaport E
    Adv Cardiol; 1986; 33():1-8. PubMed ID: 2882650
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy for acute myocardial infarction.
    Rich MW
    Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early interventions in the management of acute uncomplicated myocardial infarction.
    Friedman BM
    West J Med; 1995 Jan; 162(1):19-27. PubMed ID: 7863652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of acute myocardial infarction in the public sector in the Bahamas.
    Khetan S; Maharaj R; Davis GK
    West Indian Med J; 2000 Jun; 49(2):115-7. PubMed ID: 10948848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
    Yusuf S
    Chest; 1988 Jan; 93(1 Suppl):25S-28S. PubMed ID: 2891466
    [No Abstract]   [Full Text] [Related]  

  • 34. Limitation of infarct size after acute myocardial infarction.
    Chatterjee CK
    J Indian Med Assoc; 1988 Aug; 86(8):221-2. PubMed ID: 2906648
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacologic limitation of the size of the myocardial infarction (excluding thrombolysis)].
    Zannad F; Gilgenkrantz JM; Royer RJ
    Ann Cardiol Angeiol (Paris); 1985; 34(7):467-73. PubMed ID: 2865926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cross-sectional study of choice of drug therapy in the acute phase of treatment in acute myocardial infarct--part 1].
    Vlcek J; Gregor J; Macek K; Vítovec J; Práznovcová L; Zajíc J; Starec M; Drázka J; Kulic F; Polásek R; Jirmar R
    Vnitr Lek; 2000 Oct; 46(10):681-8. PubMed ID: 11344626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.
    McLaughlin TJ; Soumerai SB; Willison DJ; Gurwitz JH; Borbas C; Guadagnoli E; McLaughlin B; Morris N; Cheng SC; Hauptman PJ; Antman E; Casey L; Asinger R; Gobel F
    Arch Intern Med; 1996 Apr; 156(7):799-805. PubMed ID: 8615714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What intravenous treatment for myocardial infarction: beta-blockers, nitrates or thrombolysis?].
    Heikkilä J
    Duodecim; 1990; 106(1):79-98. PubMed ID: 1968377
    [No Abstract]   [Full Text] [Related]  

  • 40. Interventions that potentially limit myocardial infarct size: overview of clinical trials.
    Yusuf S
    Am J Cardiol; 1987 Jul; 60(2):11A-17A. PubMed ID: 2887096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.